HROWHARROW, INC.

Nasdaq harrowinc.com


$ 21.42 $ 0.05 (0.21 %)    

Wednesday, 26-Jun-2024 14:24:32 EDT
QQQ $ 479.64 $ 0.04 (0.01 %)
DIA $ 391.52 $ 1.42 (0.36 %)
SPY $ 544.76 $ 1.16 (0.21 %)
TLT $ 93.21 $ -0.35 (-0.37 %)
GLD $ 212.79 $ -1.40 (-0.65 %)
$ 21.64
$ 21.38
$ 0.00 x 0
$ 0.00 x 0
$ 21.17 - $ 21.58
$ 7.60 - $ 22.63
353,625
na
767.56M
$ 1.25
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 03-19-2024 12-31-2023 10-K
3 11-13-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-11-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-14-2022 09-30-2022 10-Q
8 08-09-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 03-10-2022 12-31-2021 10-K
11 11-09-2021 09-30-2021 10-Q
12 08-10-2021 06-30-2021 10-Q
13 05-11-2021 03-31-2021 10-Q
14 03-08-2021 12-31-2020 10-K
15 11-09-2020 09-30-2020 10-Q
16 08-10-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-13-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 03-12-2019 12-31-2018 10-K
23 11-13-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-08-2018 12-31-2017 10-K
27 11-14-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 03-21-2017 12-31-2016 10-K
31 11-14-2016 09-30-2016 10-Q
32 08-15-2016 06-30-2016 10-Q
33 05-12-2016 03-31-2016 10-Q
34 03-23-2016 12-31-2015 10-K
35 11-12-2015 09-30-2015 10-Q
36 08-12-2015 06-30-2015 10-Q
37 05-13-2015 03-31-2015 10-Q
38 03-12-2015 12-31-2014 10-K
39 11-12-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 craig-hallum-maintains-buy-on-harrow-raises-price-target-to-30

Craig-Hallum analyst Chase Knickerbocker maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $26 to $30.

Core News & Articles
Market-Moving News for June 20th
06/20/2024 12:17:43

HROW: 20% | Harrow shares are trading higher after the company announced the manufacture of the first of three commercial-scale...

 melt-pharmaceuticals-reports-first-patient-dosed-in-phase-3-program-of-its-melt-300-for-needle--and-opioid-free-sedation-in-patients-undergoing-cataract-surgery-topline-readout-expected-in-q4-2024

Melt Pharmaceuticals, Inc. ("Melt"), a clinical-stage pharmaceutical company developing novel approaches for procedural...

 harrows-vevye-shows-results-for-dry-eye-disease-in-essence-2-study

Harrow (NASDAQ:HROW), a leading North American eyecare pharmaceutical company, is pleased to announce results from its ESSENCE‑...

 lake-street-maintains-buy-on-harrow-raises-price-target-to-25

Lake Street analyst Brooks O'Neil maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $20 to $25.

 craig-hallum-maintains-buy-on-harrow-raises-price-target-to-26

Craig-Hallum maintains Harrow (NASDAQ:HROW) with a Buy and raises the price target from $24 to $26.

 b-riley-securities-reiterates-buy-on-harrow-raises-price-target-to-29

B. Riley Securities analyst Sahil Kazmi reiterates Harrow (NASDAQ:HROW) with a Buy and raises the price target from $26 to $29.

 harrow-health-q1-2024-adj-eps-028-misses-020-estimate-sales-34600m-miss-37268m-estimate

Harrow Health (NASDAQ:HROW) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.2...

 craig-hallum-initiates-coverage-on-harrow-with-buy-rating-announces-price-target-of-24

Craig-Hallum initiates coverage on Harrow (NASDAQ:HROW) with a Buy rating and announces Price Target of $24.